1. Home
  2. OXLC vs HELP Comparison

OXLC vs HELP Comparison

Compare OXLC & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oxford Lane Capital Corp.

OXLC

Oxford Lane Capital Corp.

N/A

Current Price

$4.92

Market Cap

498.0M

Sector

Finance

ML Signal

N/A

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

N/A

Current Price

$6.54

Market Cap

574.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OXLC
HELP
Founded
2010
2019
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
498.0M
574.7M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
OXLC
HELP
Price
$4.92
$6.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
11
Target Price
$6.00
★ $46.17
AVG Volume (30 Days)
★ 2.3M
1.8M
Earning Date
11-01-2023
11-16-2026
Dividend Yield
★ 18.86%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$136.15
N/A
Revenue Next Year
$5.51
N/A
P/E Ratio
$7.72
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.62
$3.76
52 Week High
$15.39
$15.15

Technical Indicators

Market Signals
Indicator
OXLC
HELP
Relative Strength Index (RSI) 20.13 26.96
Support Level $4.62 $4.41
Resistance Level $10.10 $8.50
Average True Range (ATR) 0.26 0.95
MACD 0.02 -0.20
Stochastic Oscillator 16.14 5.76

Price Performance

Historical Comparison
OXLC
HELP

About OXLC Oxford Lane Capital Corp.

Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize portfolio's risk adjusted total return, and currently seek to achieve investment objective by investing in structured finance investments, specifically the equity and junior debt tranches of CLO vehicles, which are collateralized by a diverse portfolio of senior secured loans made to companies whose debt is unrated or is rated below investment grade (the Senior Loans) and, to a limited. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: